Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
5
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials
Showing 5 of 5
completednot_applicable

Long-term Effect of TMS in Primary Progressive Aphasia

NCT05842473
completednot_applicable

Aerobic Exercise and Aphasia Treatment

NCT02999360
completednot_applicable

Language Development in Cochlear Implant Children

NCT04595552
completednot_applicable

Preventing Language Decline in Dementia

NCT02541097
completednot_applicable

Language Therapy in British Sign Language

NCT02579668

Clinical Trials (5)

Showing 5 of 5 trials
NCT05842473Not Applicable

Long-term Effect of TMS in Primary Progressive Aphasia

Completed
NCT02999360Not Applicable

Aerobic Exercise and Aphasia Treatment

Completed
NCT04595552Not Applicable

Language Development in Cochlear Implant Children

Completed
NCT02541097Not Applicable

Preventing Language Decline in Dementia

Completed
NCT02579668Not Applicable

Language Therapy in British Sign Language

Completed

All 5 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
5